Shellworks
London, United Kingdom· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A UK synbio firm programming microbes to build novel drug delivery vehicles.
Drug Delivery Technology
Technology Platform
A proprietary synthetic biology platform that engineers bacteria to produce self-assembling, programmable bio-shells for encapsulating and delivering therapeutic agents.
Opportunities
Potential to enable delivery of challenging therapeutic modalities (e.g., gene editors, proteins) that are limited by current formulation technology.
Risk Factors
The biological manufacturing process may face regulatory scrutiny and scalability challenges compared to more established chemical synthesis methods.
Competitive Landscape
Competes with established chemical-based drug delivery firms by offering a novel bio-fabricated alternative, but must prove scalability and reliability.